We are live on ! Find out more
TXG icon

10x Genomics
TXG

254 hedge funds and large institutions have $3.91B invested in 10x Genomics in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 96 increasing their positions, 85 reducing their positions, and 92 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 85

2.91% more ownership

Funds ownership: 88.75% → 91.66% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

19% less funds holding

Funds holding: 314 → 254 (-60)

34% less call options, than puts

Call options by funds: $13.9M | Put options by funds: $21.1M

38% less capital invested

Capital invested by funds: $6.29B → $3.91B (-$2.38B)

61% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 92

Holders
254
Holders Change
-60
Holders Change %
-19.11%
% of All Funds
4.28%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
36
Increased
96
Reduced
85
Closed
92
Calls
$13.9M
Puts
$21.1M
Net Calls
-$7.23M
Net Calls Change
+$3.98M

Top Buyers

1
GIM
Generation Investment Management
United Kingdom
+$136M
2
SIM
SRS Investment Management
New York
+$132M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$107M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$53.1M
5
JP Morgan Chase
JP Morgan Chase
New York
+$48.1M

Top Sellers

1
BlackRock
BlackRock
New York
-$121M
2
Ameriprise
Ameriprise
Minnesota
-$81.9M
3
1WCM
12 West Capital Management
New York
-$65.8M
4
Allspring Global Investments
Allspring Global Investments
North Carolina
-$55.1M
5
FAM
Fred Alger Management
New York
-$25M
Name Holding Trade Value Shares
Change 		Change in
Stake
Voloridge Investment Management
26
Voloridge Investment Management
Florida
$35.4M +$21.7M +418,718 +115%
FCMI
27
Foresite Capital Management I
California
$33.9M – – –
EVM
28
Eaton Vance Management
Massachusetts
$33.7M +$3.19M +61,411 +9%
Norges Bank
29
Norges Bank
Norway
$32.7M +$247K +4,761 +0.7%
Goldman Sachs
30
Goldman Sachs
New York
$29M -$2.33M -44,852 -7%
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$27.8M +$16.5M +317,447 +107%
GGHC
32
Gilder Gagnon Howe & Co
New York
$25.7M -$9.15M -176,294 -24%
Bank of America
33
Bank of America
North Carolina
$23.9M -$5.2M -100,295 -16%
Charles Schwab
34
Charles Schwab
California
$23.8M +$1.22M +23,494 +5%
SCV
35
Sands Capital Ventures
Virginia
$21.8M +$25M +481,770 New
UBS AM
36
UBS AM
Illinois
$20.8M -$4.95M -95,411 -17%
BAMCO Inc
37
BAMCO Inc
New York
$18.4M +$2.01M +38,672 +11%
Northern Trust
38
Northern Trust
Illinois
$17.5M -$4.57M -88,125 -19%
Russell Investments Group
39
Russell Investments Group
United Kingdom
$16M -$1.26M -24,276 -6%
DCMIC
40
Decheng Capital Management III (Cayman)
Cayman Islands
$13.8M – – –
EHI
41
Eagle Health Investments
Connecticut
$11.8M +$13.6M +261,200 New
BG
42
Bellevue Group
Switzerland
$11.7M +$338K +6,512 +3%
N
43
Nuveen
North Carolina
$10.6M +$1.6M +30,784 +15%
JSP
44
Jackson Square Partners
California
$9.55M -$19.2M -369,389 -64%
LNC
45
Lincoln National Corp
Pennsylvania
$9.51M – – –
PAMS
46
Pictet Asset Management (Switzerland)
Switzerland
$9.48M -$1.04M -20,141 -9%
Swiss National Bank
47
Swiss National Bank
Switzerland
$8.96M -$7.22M -139,224 -41%
VCM
48
Vigilant Capital Management
Maine
$8.93M +$6.24M +120,257 +156%
Mitsubishi UFJ Trust & Banking
49
Mitsubishi UFJ Trust & Banking
Japan
$8.46M -$1.97M -37,904 -17%
HMC
50
Harvard Management Company
Massachusetts
$8.42M – – –
1
2
3 4 5

TXG Hedge Fund Activity: Q2 2022 in Review

254 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in 10x Genomics (TXG) for Q2 2022, worth a combined $3.91B — down 38% from $6.29B a quarter earlier.

Sellers outnumbered buyers: 92 funds closed out of TXG and 36 opened new positions — a net loss of 56 holders — while 85 trimmed existing stakes and 96 added.

The largest buyer was Generation Investment Management, opening a new position worth an estimated $136M. The largest seller was BlackRock, cutting an estimated $121M.

  • 254 institutional investors held 10x Genomics (TXG) as of Q2 2022, down from 314 in Q1 2022.
  • Funds reported $3.91B of 10x Genomics stock for Q2 2022, down 38% quarter-over-quarter.
  • 36 funds opened new 10x Genomics positions in Q2 2022 and 92 closed out, a net change of -56 holders.
  • The largest 10x Genomics buyer in Q2 2022 was Generation Investment Management, an estimated $136M added.
  • The largest 10x Genomics seller in Q2 2022 was BlackRock, an estimated $121M sold.

Based on aggregated 13F filings for Q2 2022.